Baseline patient characteristics for trabeculectomy and glaucoma drainage device (GDD) groups
| Characteristics | Trabeculectomy | GDD | p Value |
|---|---|---|---|
| †MMC, mitomycin C trabeculectomy; 5-FU, 5-fluorouracil trabeculotomy; Complete, complete Baerveldt implant; Stage 2, second stage of Baerveldt implant. | |||
| ‡POAG, primary open angle glaucoma; 2OAG, secondary open angle glaucoma; CACG, chronic angle closure glaucoma; NVG, neovascular glaucoma. | |||
| Sex | |||
| Male | 15 (39%) | 7 (32%) | |
| Female | 24 (61%) | 15 (68%) | 0.8 |
| Race | |||
| White | 16 (41.0) | 11 (50.0) | |
| Black | 49 (10.3) | 3 (13.6) | |
| Asian | 9 (23.1) | 5 (22.7) | |
| Latino | 10 (25.6) | 3 (13.6) | 0.8 |
| Age (years) (mean (SD)) | 69.5 (11.2) | 71.4 (12.2) | 0.55 |
| Surgical procedure† | MMC 36 (92%) | ||
| 5-FU 2 (5%) | Complete 13 (59%) | ||
| None 1 (3%) | Stage 2 9 (41%) | ||
| Lens status | |||
| Phakic | 15 (38%) | 4 (18%) | |
| Pseudophakic | 23 (59%) | 18 (82%) | |
| Aphakic | 1 (3%) | 0 (0%) | 0.17 |
| Diagnosis‡ | |||
| POAG | 32 (82%) | 16 (73%) | |
| 2OAG | 1 (2.5%) | 4 (18%) | |
| CACG | 5 (13%) | 0 (0%) | |
| NVG | 1 (2.5%) | 2 (9%) | 0.04* |
| Preoperative IOP (mm Hg) (mean (SD)) | 22.8 (9.7) | 25.2 (8.4) | 0.33 |